Type 2 Diabetes

Diabetes drug TV, print advertising gets approval of Mexico's medical regulator

Published in Obesity and Diabetes Week, April 4th, 2005

The president of Biotech Holdings said that the company's television advertising materials for Sucanon, its diabetes drug, meets new requirements that have been established by Mexico's medical regulator.

The company president said that new regulatory policies in Mexico require that any advertising that makes medical claims must have prior approval from the Mexican national regulator.

The company's diabetes drug, Sucanon, which has been approved for the treatment of symptoms of type 2 diabetes, is now sold in more than 600 stores nationally in Mexico, including outlets of at least 4 drugstore chains.

Biotech Holdings Ltd.'s head...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2005-04-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry